601607 Shanghai Pharmaceuticals Holding

Watchlist

21.37
0.000.00%

Not Open Dec 4 15:00 CST

79.23BMarket Cap19.68P/E (TTM)

About Shanghai Pharmaceuticals Holding Company

The company is a large pharmaceutical industry group listed in Shanghai and Hong Kong. The main business covers the pharmaceutical industry and commerce, and ranks among the Fortune 500 and the top 50 global pharmaceutical companies. Its comprehensive strength ranks in the top three Chinese pharmaceutical companies, and is selected as a constituent stock of the Shanghai Composite 180 Index, the Shanghai and Shenzhen 300 Index, and the Morgan Stanley China Index (MSCI). The company's main business covers the pharmaceutical industry and pharmaceutical business. The company's main products: hydroxychloroquine sulfate tablets, injectable usastatin, tanshinone IIA sodium sulfonate injections, polysaccharide iron complex capsules, and bifidobacteria trifecta active bacterial preparations. Corporate honors: “2023 Asia Pacific Quality Organization - Innovation Award”, the company won 27 national quality awards, 112 provincial and municipal quality awards, the “Fortune 500” list, and won the “Top 50 Global Pharmaceutical Companies”, “Top 25 Global Pharmaceutical Brands”, “China's Top 100 Pharmaceutical Industry Companies”, and “China's Top 100 Pharmaceutical Industry Companies”, and “Best Industrial Enterprise in China's Pharmaceutical R&D Product Line”, ranked 473rd among the 2020 Fortune Global 500, and is one of only two Chinese pharmaceutical companies; In “Fortune It ranked 57th in the 2020 Fortune China 500 published by “Fortune” (Chinese version); ranked 1009th in the 2020 Global Top 2000 Companies published by “Forbes”; and ranked 2nd in the overall strength of China Pharmaceutical Group;

Company Profile

Short Name-A上海医药

Symbol-A601607

Short Name-H上海医药

Symbol-H02607

Company NameShanghai Pharmaceuticals Holding Co.,Ltd.

Listing DateMar 24, 1994

Issue Price4.50

Shares Offered15.00M share(s)

FoundedJan 18, 1994

Listed ExchangeSH Stock Exchange

Legal Representativeqiuhua yang

General Managerbo shen

Secretarytao zhong

Accounting FirmDeloitte Huayong Certified Public Accountants (Special General Partnership)

Securities Representativeyesunshiyi lu

Legal CounselGuo Hao Law Firm (Shanghai)

Employees49234

Phone8621-63730908

Office AddressShanghai Pharmaceutical Building, 200 Taicang Road, Shanghai, China

Zip Code200020

Registered AddressNo. 92, Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone

Fax8621-63289333

Emailpharm@sphchina.com

Websitehttp://www.sphchina.com

Business License310000000026221

BusinessAPIs and pharmaceutical products of various dosage forms (including but not limited to tablets, capsules, aerosols, immune preparations, granules, ointments, pills, oral solutions, inhalants, injections, linings, tinctures, suppositories) (including but not limited to chemical raw materials, chemical preparations, Chinese herbal medicines, proprietary Chinese medicines, Chinese herbal medicines, traditional Chinese medicines, Chinese medicine tablets, biochemicals, biological products, narcotic drugs, psychotropic drugs, medical toxic drugs [adapted to the scope of business], vaccines), health products, medical drug research and development products Development, manufacturing and sales, medical equipment manufacturing, sales and engineering installation, maintenance, warehousing and logistics, offshore , land and air freight forwarding business, industrial investment, asset management, provision of international economic and trade information and consulting services, leasing of own housing, and import and export business of all kinds of pharmaceuticals and related commodities and technology (the above refers to licensed operations operated by license).

Company Executives

Name
Position
Salary

qiuhua yang
Chairman, Executive Director, Member of the Remuneration and Assessment Committee, Strategy Committee Convener
--

wenxue zhang
Non-executive Directors, Strategy Committee Member
--

yongzhong li
Executive Director, Executive President
6.03M

bo shen
Executive Director, President, Chief Financial Officer, Nomination Committee Members
5.64M

ming dong
Executive Director
--

zhong wang
Independent Non-Executive Director, Remuneration and Assessment Committee Convener, Strategy Committee Member, Audit Committee Member
150.00K

wenxun huo
Independent Non-Executive Director, Audit Committee Member, Nomination Committee Convener
300.00K

chaoyang gu
Independent Non-Executive Director, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Audit Committee Convener
300.00K